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                                                                        INTRODUCTION 
 
Pharmaceutical Analysis1,2is the branch of chemistry involved in separating, identifying and 
determining the relative amounts of the components making up a sample of matter. It is 
mainly involved in the qualitative identification or detection of compounds and quantitative 
measurements of the substances present in bulk and pharmaceutical preparation. 
Pharmaceutical analysis derives its principles from various branches of science like 
Chemistry, Physics, Microbiology, Nuclear Science, Electronics, etc. Analytical method is a 
specific application of a technique to solve an analytical problem. Analytical instrumentation 
plays an important role in the production and evaluation of new products and in the 
protection of consumers and the environment. This instrumentation provides the lower 
detection limits required to assure safe foods, drugs, water and air. 
Analytical chemistry3deals with methods for determining the chemical composition of 
samples of matter. A qualitative method yields information about the identity of atomic or 
molecular species or the functional groups in the sample. A quantitative method, in contrast, 
provides numerical information as to the relative amount of one or more of these 
components. 
TYPES OF ANALYSIS4 
Proximate analysis- The amount of each element in a sample is determined with no                                
concern as to the actual compound present 
Partial analysis- The selected constituent in a sample is determined by partial analysis 
Trace constituent analysis- The very minute quantity of a specified component in a                                                                      
sample is determined by this method. 
 
 
 
  
 
Complete analysis  Based upon 
1)Quantitative chemical analysis based on chemical reactions      
Gravimetry 
Titrimetry 
Volumetry 
2) Appropriate electrical measurements 
3) Mechanical properties 
4) Thermal properties 
5) Nuclear properties 
6) Properties involving interaction with radiation 
7) Chromatography 
8) Hyphenated techniques 
CHROMATOGRAPHY 
Definition 
Chromatography is a non-destructive procedure for resolving a complex mixture into its 
individual fractions (or) compounds. 
Principle 
The samples are subjected to flow by mobile liquid phase onto (or) through the stable 
stationary phase. As in the definition, the principle involved is separation of fractions of 
mixture based on their relative affinity towards the two phases during their travel. The 
fraction with greater affinity to stationary phase travels slower. While that with less affinity 
travels faster. 
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TYPES OF CHROMATOGRAPHY6,1 
Based on the mode employed in separation chromatography is broadly classified as 
1.Adsorption mode 
The stationary phase is a solid while the mobile phase is liquid. The compounds travel on the 
stationary phase under the influence of mobile phase based on their relative adsorption to the 
solid stationary phase. 
2. Partition mode 
In this mode, both the stationary and mobile phase was liquids. So the compounds have 
affinity based on their partition into the individual liquid phases. The one with greater 
partition to stationary phase has higher affinity to stationary phase and vice versa. 
Based on the nature of stationary phase, it is of two types 
A) Normal phase chromatography 
Here the stationary phase is polar in nature and hence the compounds with higher polarity 
elute out last while non-polar  come out first. 
B) Reverse phase chromatography 
Here the stationary phase is non-polar in nature and hence the compounds with lower polarity 
elute out last and vice-versa. 
Chromatography methods can be broadly divided into planar chromatography and columnar 
chromatographic methods. 
In planar chromatography, the stationary phase is a plane surface i.e. (two dimension 
surface where only length and breadth are taken as area) on which chromatograms are 
formed. 
 
 
 
  
 
This method is adopted in techniques like:-  
1. Paper chromatography5This technique is a type of partition chromatography in 
which the substances are distributed between two liquids i.e one is the stationary 
liquid(usually water) which is held in the fibers of the paper and called the stationary phase. 
The other is the moving liquid or developing solvent and called the moving phase. The 
components of the mixture to be separated migrate at different  rates and appear as spots at 
different points on the paper.  
2. Thin layer chromatography4It is similar to paper chromatography except that a thin 
(0.25mm) layer of some inert material. The important difference between TLCand HPLC is 
one of practical technique rather than of the physical phenomena( adsorption, partition, etc.) 
on which separation is based. Thus in TLC the stationary phase consists of a thin layer of 
sorbent (e.g. silica gel or cellulose powder) coated on an inert, rigid, backing material such as 
a glass plate or plastic foil so that the separation process occurs on a flat essentially two-
dimensional surface. Although TLC is widely used for qualitative analysis, it does not in 
general provide quantitative information of high precision and accuracy. Yasa4 
4. Gas-liquid chromatography3 The mobile phase is a gas and the stationary phase is a 
thin  layer of a non-volatile liquid bound to a solid support. Partition process occurs. 
5. High performance thin layer chromatography (HPTLC):- 
In Columnar chromatography, there is use of a column on whose walls lies a 
stationary phase and the mobile phase is flushed through the column. 
The techniques which employ this method are:- 
1. Column chromatography5Also known as adsorption chromatography. In this 
method, the mixture to be separated  is dissolved in a suitable solvent and allowed to pass 
through a tube containing the adsorbent. The component which has greater absorbing power 
is adsorbed in the upper  portion of the column. The next component is adsorbed in the lower 
portion of the column which has  lesser adsorbing power than the first component. This 
process is continued. As a result the materials are partially separated and adsorbed in the 
various parts of  the column. The initial separation of the various components can be  
 
  
 
improved by passing  either the original or some other suitable solvent slowly through the 
columns. The various bands present in the column become more defined. The banded column 
of adsorbent is termed a chromatogram, and the operation is spoken of as the developmentof 
chromatogram . the portion of a column which is occupied by a particular substance is called 
its zone. The narrower the zones, the longer the  number of substances which can be 
separated in a column of a definite length, and the more concentrated are the elutes. 
2. Gas-solid chromatography3It utilizes a solid adsorbent as the stationary phase, and 
an adsorption process takes place. 
3. High Pressure liquid chromatography (HPLC)7In this system pressure is 
applied to the column, forcing the mobile phase through at much higher rate. The pressure is 
applied using a pumping system. The action of the pump is critical, since it must not pulsate 
and mix up the sample being separated in the solvent, causing it to lose resolution. 
4. Size exclusion chromatography1It uses a porous material as the stationary phase 
and a liquid as a mobile phase. The diameters of the pores of the material are of the order of 
50-3000A, Which is similar to the size of many molecules. The latter penetrate the pores 
according to their size. Small molecules penetrate more rapidly than larger molecules, which 
frequently are excluded from the smaller pores present. This results in a difference in the 
rates at which the molecules pass down the column, the smaller molecules travelling faster 
than the larger molecules. 
5 .Ion-exchange chromatography1Ion exchange  chromatography is the process based  
on exchange equilibria between ions in solution and ions of like sign on the surface of an 
essentially insoluble high molecular mass solid . Natural ion exchangers are clay and zeolite. 
Synthetic resins are : strong acid cation exchangers; weak acid cation exchangers; strong base 
anion exchangers; and weak base anion  exchangers. 
 
 
 
 
 
  
 
Analytical method development 8 
The number of drugs introduced into the market is increasing every year. These drugs may be 
either new entities or partial structural modification of the existing one. Very often there is a 
time lag from the date of introduction of a drug into the market to the date of its inclusion in 
pharmacopoeias. This happens because of the possible uncertainties in the continuous and 
wider usage of these drugs, reports of new toxicities (resulting in their withdrawal from the 
market), development of patient resistance and introduction of better drugs by competitors. 
Under these conditions, standards and analytical procedures for these drugs may not be 
available in the pharmacopoeias. It becomes necessary, therefore to develop newer analytical 
methods for such drugs.  
Basic criteria for new method development of drug analysis 
The drug  may not be official in any pharmacopoeias, 
A proper analytical procedure for the drug may not be available in the literature due to patent 
regulations, 
Analytical methods may not be available for the drug in the form of a formulation due to the 
interference caused by the formulation excipients, 
Analytical methods for the quantitation of the drug in biological fluids may not be available, 
Analytical methods for a drug in combination with other drugs may not be available, 
The existing analytical procedures may require expensive reagents and solvents. It may also 
involve cumbersome extraction and separation procedures and these may not be reliable. 
 
 
 
 
 
 
  
 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY9 
 
In 1903, Mikhail Tswett discovered Chromatography technique. It serves as a means of 
resolution of mixtures. The name suggests Chroma meaning “colour and graphein means 
“write”. 
HPLC is one of the types of Chromatography. In modern pharmaceutical industries, HPLC is 
the major and integral analytical tool applied in all stages of drug discovery, development, 
and production. Effective and fast method development is of paramount importance 
throughout this drug development life cycle. This requiresathorough understanding of HPLC 
principles and theory which lay a solid foundation for appreciating the many variables that 
are optimized during fast and effective HPLC method development and optimization. 
 
HPLC as compared with the classical LC technique is characterized   by 
high resolution12 
small diameter (4.6 mm), stainless steel, glass or titanium columns; 
column packing with very small (3, 5 and 10 μm) particles; 
relatively high inlet pressures and controlled flow of the mobile phase; 
continuous flow detectors capable of handling small flow rates and detecting very small 
amounts 
rapid analysis; 
 
Initially, pressure was selected as the principal criterion of modern liquid chromatography 
and thus the name was "high pressure liquid chromatography" or HPLC. This was, however, 
an unfortunate term because it seems to indicate that the improved performance is primarily 
due to the high pressure. This is, however, not true. In fact, high performance is the result of 
many factors: very small particles of narrow distribution range and uniform pore size and 
distribution, high pressure column slurry packing techniques, accurate low volume sample 
injectors, sensitive low volume detectors and, of course, good pumping systems. Naturally, 
pressure is needed to permit a given flow rate of the mobile phase. 
 
 
 
 
  
 
HPLC separations are based on the surface interactions, and depend on the types of the 
adsorption sites. Modern HPLC adsorbents are the small rigid porous particles with high 
surfacearea. 
Main adsorbent parameters are13 
 Particle size: 3 to 10 μm 
Particle size distribution: as narrow as possible, usually within 10% of the mean; 
The last parameter in the list represents an adsorbent surface chemistry. 
Depending on the type of the ligand attached to the surface, the adsorbent could 
be normal phase (-OH, -NH2), or reversed-phase (C5, C8, C 18 CN, NH2 ), and even anion 
(CH2NR3+OH-), or cation (R-SO3-H+) exchangers. 
 
Principle10 
The principle of separation is normal phase mode and reverse phase mode is adsorption. 
When mixtures of components are introduced in to a HPLC column, they travel according to 
their relative affinities towards the stationary phase. The component which has more affinity 
towards the adsorbent travels slower.  
The component which has less affinity towards the stationary phase travels faster. Since no 
two components have the same affinity towards the stationary phase, the components are 
separated. 
Most of the drugs in multicomponent dosage forms can be analyzed by HPLC method 
because of the several advantages like rapidity, specificity, accuracy, precision and ease of 
automation in this method. HPLC method eliminates tedious extraction and isolation 
procedures.  
Mechanism of separation14 
                                      Reversed phase chromatography is performed on a nonpolar 
stationary phase with a polar mobile phase. In RPLC, solute retention is mainly due to 
hydrophobic interactions between the solutes and the nonpolar hydrocarbon stationary 
surface. The nonpolar components of a sample interact more with the relatively nonpolar 
hydrocarbon column packing and thus elute later than polar components. In NPLC, many 
types of interaction have been described, but hydrogen bonding often predominates.  
 
  
 
 
The elution order of solutes in RPLC is in the order of decreasing polarity, i.e., increasing 
hydrophobicity, while in NPLC the least polar compound elutes first. Thus, NPLC and RPLC 
are complementary in elution order. The general theory to describe separation is, however, 
similar. The analyte is capable of adsorbing to and desorbing from the stationary phase, so it 
migrates through the column more slowly than the solvent. The width of the analyte band is 
limited at a theoretical minimum by the volume in which the analyte is injected and is 
increased by processes that tend to disperse the band, such as diffusion of the analyte in the 
mobile phase. 
 
 In HPLC, the type and composition of the eluent is one of the variables influencing the 
separation.Despite the large variety of solvents used in HPLC, there are several common 
properties: 
Purity 
Detector compatibility 
Solubility of the sample 
Low viscosity 
Chemical inertness 
For normal phase mode, solvents are mainly nonpolar; for reversed-phase, eluents are usually  
mixture of water with some polar organic solvent such as acetonitrile or methanol. 
Size-exclusion HPLC has special requirements. SEC eluents have to dissolve polymers, but 
the most important is that SEC eluent has to suppress possible interactions of the sample 
molecule with the surface of the packing material. 
 
 
  
 
Instrumentation3,13,15
 
                                                         Fig-1444 
Modern hplc instruments requires several hundreds of atmospheres to achieve reasonable 
flow rates. Because of these high pressures the equipment in hplc is more elaborate n 
expensive.It consists of 
1Mobile-phasereservoirs and solvent systems   A modern hplc apparatus is 
equipped with one or more glass reservoirs. Provisions are often included to remove 
dissolved gases and dust. Degassers may consists of a vaccum pumping system, a distillation 
system,a device heating and stirring. A system for sparging is also incorporated, in which the 
dissolved gases are swept out of  solution by fine bubbles of inert gas. An elution may be of 
two types isocratic in which a solvent or mixture of constant composition is used, And 
gradient which consists of two solvents that differ  significantly in their polarities and used in 
varied composition during the separation. 
2 Pumping system The pumping system is one of the most important features of an 
HPLC system. There is high resistance to solvent flow due to the narrow columns packed 
with small particles, and high pressures are therefore required to achieve satisfactory flow 
rates.  
 
  
 
The main feature of a good pumping system is that it is capable of output of  at least 3.4×107 
Pa (5000 p.s.i) and ideally there must be no pulses of flow through the system. There must be 
a flow delivery of  at least 10 cm3 min-1 for normal analysis and upto 30 cm3 min -1 for  
preparative analysis. All material in the pump should be chemically resistance to all solvents. 
Various pumping systems are available 
Pneumatic Pumps 
They are mostly used for preparative purpose or chosen for the slurry packing of column. It 
uses the pressurized gas as source to drive the mobile phase to the column.  
Syringe Type Pumps 
 It works on the principle of positive solvent displacement by a piston mechanically driven at 
a constant rate in a piston chamber of about 250-500 ml capacity with the generation of 
pulseless flow with high pressure capabilities (200-475 atm).   
Reciprocating Pumps  
This is generally electrically driven; the driven piston pressurizes the eluent. In this type the 
movement of plunger piston causes the suction of the eluent during the backward stroke and 
the delivery of the pressurized solvent during the forward stroke.       
Hydrualic pumps 
 These pumps also work on the same principle as that of the pneumatic pumps, but use liquid 
pressures rather than gas pressures. 
During the chromatographic experiment, a pump can deliver a constant mobile phase 
composition (isocratic mode) or a variable mobile phase composition (gradient mode). 
which operate on the principle of constant pressure or constant displacement. 
Constant pressure pumps 
 It  produce a pulseless flow through the column, these pumps operate by the introduction of  
high pressure gas into the pump, and the gas in turn forces the solvent from the pump into the 
column.  
Constant displacement pumps 
 It maintains a constant flow rate through the column irrespective of changing conditions 
within the column. One form of constant displacement pump is a motor-driven syringe type 
pump where a fixed volume of  solvent is forced from the pump to the column by a piston 
driven by a motor.  
 
 
 
  
 
Modern pumps have the following parameters: 
Flow rate range: 0.01 to 5 mL/min 
Flow rate stability: not more than 1% 
For SEC flow rate stability should be less than 0.2% 
Maximum pressure: up to 300 hPa  
Fig-242 
Pumping system 
3 Sample injection systemsThe sample introduction system should enable the sample to 
be introduced as a narrow plug onto the column so that peak broadening is negligible. Two 
means for analyte introduction on the column are injection into a flowing stream and a stop 
flow injection. These techniques used can be fixed volume valve injection, variable valve 
injection or septum injection. The injector serves to introduce the liquid sample into the flow 
stream of the mobile phase. Typical sample volumes are 5-20 microliters (µl). The injector 
must also be able to withstand the high pressures of the liquid system.  
Manual Injector manually loads sample into the injector using a syringe and then turns the 
handle to inject sample into the flowing mobile phase which transports the sample into the 
beginning (head) of the column, which is at high pressure.An autosampler is the automatic 
version, used when the user has many samples to analyze or when manual injection is not 
practical. Automatic injector is a microprocessor-controlled version of the manual universal 
injector. Usually, up to 100 samples can be loaded into the auto injector tray. 
  
 
 The system parameters such as flow rates, gradient run time, volume to be injected etc. are 
chosen, stored in memory and sequentially executed on consecutive injections. 
4 Column 
Columns are considered as the “heart of the chromatograph”. The column’s stationary phase 
separates the sample components of interest using various physical and chemical parameters. 
The small particles inside the column are what cause the high backpressure at normal flow 
rates. The pump must push hard to move the mobile phase through the column and this 
resistance causes a high pressure within the chromatograph. 
Types of Columns used in HPLC 
Analytical [internal diameter (i.d.) 1.0 - 4.6-mm; lengths 15 –250 mm] 
Preparative [i.d.> 4.6 mm; lengths 50 –250 mm] 
Capillary [i.d. 0.1 -1.0 mm; various lengths] 
Nano [i.d.< 0.1 mm, or sometimes stated as < 100 µm] 
Materials of construction used for the tubing 
Stainless steel (the most popular; gives high pressure capabilities) 
Glass (mostly for biomolecules) 
PEEK polymer (biocompatible and chemically inert to most solvents) 
Column-Packing Materials 
HPLC columns are either polymers or silica based. Silica based packings are the most 
popular and often used systems. The chemical natures of these packings vary with the 
stationary phase; their physical characteristics are similar. The average particle diameter of 
the packings is between 3 to 10 µ with a narrow size distribution. The columns of smaller 
particles permit faster separation than columns of larger particle size. Higher strength 
particles provide columns that exhibit lower back pressures and longer lifetime. The silica 
surface contains various kinds of SiOH (silanol) groups and those particles heated at high 
temperatures, e.g., 800°C, are devoid of such groups and hence cannot be used for columns. 
Free silanols are undesirable for the separation of the basic molecules. The addition of 
appropriate alkali can eliminate problems of secondary interactions between the basic 
compounds and acidic silanols (e.g; triethylamine). The secondary reaction between the 
acidic solutes can also be prevented by the addition of small amount of carboxylic acid into 
the mobile phase. 
 
 
  
 
Most bonded phase silica packings are made surface-reacted organosilanes. Various alkyl and 
alkyl substituted silica are made with this reaction. A few packings use a polymerized surface 
layer that results from the reaction of di or tri functional silanes with silica particles. The 
stability of the bonded phase is important in HPLC reproducibility. Long chain alkyl bonded 
phase packings (e.g C8 or C18) generally are more stable than monomeric phases (e.g, diols). 
End capping is often used to more completely bond (silanize) packings and consists of a 
subsequent reaction with trimethylchlorosilane or hexamethyldisilane, to increase the cover 
support and to minimize unwanted reaction with free silanols. 
Reversed phase separations can be made using polymer (polystyrene) particles, which are 
spherical and porous. Such polymeric (nonsilica) particles can withstand solutions with pH 2 
to 13, where silica columns degrade gradually, normally reverse phase separations can be 
made  with C8, C18, C3, C4, phenyl ethyl, cyano, amino, polystyrene packings  while normal 
phase separations must utilize cyano, diol, amino and pure silica packings.  
 
.  
Fig-341 
5 Detectors  Many different detectors are used in RPLC, including ultraviolet-visible 
spectrophotometers (UV-VIS), refractive index (RI) detectors, electrochemical (EC) 
detectors, evaporative light-scattering detectors, fluorimeters, and others. The function of the 
detector in HPLC is to monitor the mobile phase as it emerges from the column. The detector 
provides an output to a recorder or computer that result in the liquid chromatogram.  
 
 
  
 
 
Generally, HPLC detectors are classified as Bulk Property Detector which detect based on 
differential measurement of a property, which is common to both the sample and the mobile 
phase and Solute Property Detector which respond to a physical property of the solute, 
which is not exhibited by the pure mobile phase.  
The various detectors are detailed below 
UV/UV-VIS Detectors:- 
The most widely used detector in HPLC is the UV-absorption spectrophotometer detector. In 
this detector the changes in UV-absorption when the solution passes through a flow cell is 
measured.UV detectors are concentration sensitive and have the advantage that they don’t 
destroy the solute. The continuous emission of energy by deuterium lamp as a light source, 
with the wavelength of its light ranging from 190 to 380 nm can be utilized in conjunction 
with a monochromator to provide a variable wavelength detector. The variable wavelength 
facility is extremely useful for getting better sensitivity in difficult analysis as solutes can be 
monitored at their wavelength of maximum absorption. If components are to be detected at 
wavelength longer than this, a UV-VIS detector is used, which employs an additional 
tungsten lamp (W lamp).The stability of current detector is such that the concentrations of 
few nanograms can be measured. Different components have a different spectrum. 
Components with a large molar extinction coefficient can show a large peak even in small 
amounts. Not all molecules possess sufficiently strong UV chromophore for satisfactory UV 
absorption. Bile acids, lipids, sugars etc., are examples of such compounds. Today such 
molecules are detected by the process of derivatisation when a chromophoric group is 
attached to the solute either at pre-column or post column level. 
  
 
Fig-443 
Diode Array Detector (DAD)/ Photodiode Array Detector (PDA) 
Photodiode arrays or semiconductor devices are used in the detection unit. A DAD detects 
the absorption in UV to VIS region. While a UV-VIS detector has only one sample-side light-
receiving section, a DAD has multiple photodiode arrays to obtain information over a wide 
range of wavelengths at one time, which is a merit. If the measurement is performed at a 
fixed wavelength, components are identified from only their retention time; thus, a minor 
deviation in retention time can make identification of components difficult. In such a case, 
the DAD can be used to identify components by a comparison of the spectrum. 
Fluorescence Detector 
A fluorimetric detector is extremely sensitive when compared to UV-Visible detector and 
works on the principle that the fluorescent energy emitted at a longer wavelength, known as 
emission wavelength, is proportional to the concentration. First, however the solute has to be 
excited with the excitation wavelength energy, this wavelength is always lower than the 
emission wavelength, but solute has to possess initial fluorescence. Analytes with no 
fluorescence can react with compounds, which are fluorescent derivatizing agents, as in UV 
detectors to produce fluorescence.It allows to quantify and identify compounds and 
impurities in complex matrices at extremely low concentration levels (trace level analysis). 
 
 
  
 
Differential Refractive Index (RI) Detector 
The ability of a compound or solvent to deflect light provides a way to detect it. The RI is a 
measure of molecule’s ability to deflect light in a flowing mobile phase in a flow cell relative 
to a static mobile phase contained in a reference flow cell.The amount of deflection is 
proportional to concentration.The RI detector is considered to be a universal detector but it is 
not very sensitive. Any component in the eluate can be detected; thus, the RI detector is often 
called a “universal detector”. This detector is at least three times as sensitive as the UV-
visible detector, but variations in ambience produce several fluctuations. 
Conductivity Detector 
Electrochemical detectors also very sensitive, but its usage is restricted to only oxidation and 
reductions. The system works on the principal of polarography. A serious drawback of this 
detector is that the electrodes get contaminated and poisoned by absorption of the oxidized or 
reduced compounds. A conductivity detector is employed as a detector in an ion 
chromatograph, which is a system dedicated to measuring ions. This detector is used mainly 
to measure inorganic ions and small organic substances, including organic acids and amines. 
The conductivity detector is highly sensitive, but very susceptible to the effect of temperature 
variation (a change of 1ºC in solution temperature causes a change of roughly 2% in electric 
conductivity). Various methods of avoiding temperature variations have been devised, such 
as constant-temperature cells. 
Evaporative Light Scattering Detector (ELSD) 
An ELSD atomizes the column eluate, shines light on the resulting particulate components, 
and detects the resulting scattered light. Theoretically, an ELSD can detect any nonvolatile 
component. An ELSD has sensitivity roughly 10 times higher than an RI detector, but has a 
slightly low sensitivity to low molecular components due to their small size. An ELSD is 
used mainly to detect non-UV-absorbing components. Attention should be given to the fact 
that nonvolatile salts cannot be used as the eluent. 
 
 
 
  
 
Charged Aerosol Detector 
Like an ELSD, CAD atomizes the column eluate to make the sample components particulate. 
However, a CAD detects them electrically by ionizing them with charged N2 gas. A merit of 
the CAD is the ability to detect components with sensitivity higher than that of an ELSD, 
with a sensitivity which depends only slightly on component. The eluent for a CAD is similar 
to that for ELSD.In addition, the LC-MS system, in which the components separated by 
HPLC are further analyzed using a mass spectrometer, is becoming widely used because of 
its high sensitivity and the possibility of specific detection. 
Data Recorder 
Frequently called the data system, the computer not only controls all the modules of the 
HPLC instrument but it takes the signal from the detector and uses it to determine the time of 
elution (retention time) of the sample components (qualitative analysis) and the amount of 
sample (quantitative analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
PREFFERED EXPERIMENTAL CONDITIONS FOR THE INITIAL 
HPLC SEPERATION16 
 
TABLE 2 
 
 
 
Separation variable 
 
 
Preferred Initial choice 
Column 
 
     Dimensions 
     Particle size 
     Stationary phase 
 
 
15*0.46 
5micro m 
C8 or C18 
Mobile phase 
    Solvents A and B 
    %B 
     Buffer (compound, pH, concentration) 
 
Buffer- Acetonitrile 
80-100% 
25mM potassium phosphate  2.0 pH 3.0 
 
Additives (amine modifiers, ion-pair reagents)        
 
Do not use initially 
 
Flow rate 
 
1.5-2.0ml/min 
 
Temperature 
 
35-45c 
Sample size 
Volume 
Weight 
 
Less than 25micro  
Less than 100 micro g 
 
 
 
 
 
 
 
  
 
HIGH PERFORMANCE THIN LAYER  
CHROMATOGRAPHY17 
Thin layer chromatography (TLC); also known as planar-chromatography or flatbed 
chromatography is like all other chromatographic techniques, a multi-stage distribution 
process. HPTLC is the most simple separation technique today available to the analyst. It can 
be considered a time machine that can speed your work and allows you to do many things at a 
time usually not possible with other analytical techniques. 
Chromatography is a powerful separation technique that finds application to all branches of 
science 18. Chromatography is a separation technique whereby the components of a mixture 
may be separated by allowing the sample to be transported through packed bed of material by 
fluid mobile phase 19,20. Out of almost 700 pharmaceutical formulations that are documented 
in the USP almost 43% of theprocedures are those documented by thin layer chromatography. 
Features of HPTLC 
1. Simultaneous processing of sample and standard - better analytical precision and 
accuracyless need for Internal Standard 
2. Several analysts work simultaneously 
3. Lower analysis time and less cost per analysis 
4. Low maintenance cost 
5. Simple sample preparation - handle samples of divergent nature 
6. No prior treatment for solvents like filtration and degassing 
7. Low mobile phase consumption per sample 
8. No interference from previous analysis - fresh stationary and mobile phases foreach 
analysis - no contamination 
 
  
 
Table-3 
Main difference of HPTLC and TLC 14 
 
 
PARAMETER HPTLC TLC 
Layer of Sorbent 100µm 250µm 
Efficiency 
High due to smaller particle size 
generated 
Less 
Separations 3 - 5 cm 10 - 15 cm 
Analysis Time 
Shorter migration distance and 
the analysis time is greatly 
reduced 
Slower 
Solid support 
Wide choice of stationary phases 
like silica gel for normal phase 
and C8 , C18 for reverse phase 
modes 
Silica gel, Alumina &      
Kiesulguhr 
Development 
chamber 
New type that require less 
amount of mobile phase 
More amount 
Sample spotting Auto sampler Manual spotting 
Scanning 
Use of UV/ Visible/ 
Fluorescence scanner scans the 
entire chromatogram 
qualitatively and quantitatively. 
The scanner is an advanced type 
of densitometer. 
Not possible 
 
  
 
INSTRUMENTATION46 
 1.Platecoaters 
2.Drying racks 
3.Platecutters 
4.Immersion device 
5.Plateheater 
6Sample application 
7.Development chamber 
8.Derivatization devices 
9.Scanning densitometer 
1.Platecoate.Handoperated•The manual plate coater functions in the same manneras the 
automatic coater , exceptwith this model the plates are pushed through by hand , one after the 
other and lifted off on the other slide.    
1Automatic Plate CoaterThe glass plates to be coated are conveyed underneath a hopper 
filled with the adsorbent suspension.The plates are moved by a motorizedconveying system 
at a uniform feedingrate of 10cm/s, to ensure a uniform speed.  
2.Drying RackThe Drying Rack consists of ten  individual aluminum trays. A tin box for 
storing the trays and twowire handles , to move the stack while hot ,are supplied. The drying 
rack is convenient to use ,particularly when TLC plates are preparedwith the automatic plate 
coater in large runs. 
3.Plate CutterUsed to cut HPTLC plates easily and more precisely. Cuts plates with a 
thickness up to 3mm.Does not damage the sensitive layer. Easy to handle .Read the required 
size from the scale directly. Helps saving costs on pre-coated platesof high quality by 
preventing off cuts. 
4.ImmersionDeviceFor proper execution of the dipping technique , the chromatogram must 
be immersed and withdrawnat a controlled uniform speed.Uniform vertical speed Immersion 
time selectable between 1 and 8 seconds.The device can be set to accommodate 10cm and 
20cm plate height. Battery operated , independent of power supply.  
 
 
 
 
  
 
5.PlateHeaterThe TLC plate heater is designed  for heating TLC platesto a given 
temperature , while ensuring homogenous heating across the plate. The TLC plate heater has  
a heating surfacewhich is resistant to all common reagents and is easily cleaned. Programmed 
and actual temperature are digitallydisplayed.The temperature is selectable between 25 and 
2000c.The plate heater is protected from overheating. 13 
6.SampleApplicationUsual concentration of applied samples 0.1 to 1 µg / µl for qualitative 
Analysis and quantity may vary in quantitation based on UV absorption 1 to 5 µl for spot and 
10 µL for band application. 
Manual, Semi-Automatic, Automatic Application 
Manual with calibrated capillaries. 
Semi and auto-application through applicators. 
Applicators use spray on or touch and deliver technique for application.  
7. Developing Chamber 
1.Twin trough chamber        
2. Automatic developing chamber 
1.Twin Trough Chamber 
 Low solvent consumption:20 mL of solvent is sufficient for the development of a 20x20cm 
plate.  This not only saves solvent , but also reduces the waste disposal problem 
Reproducible pre –equilibrium with Solvent  vapor: For pre-equilibration, the TLC plate is 
placed in the empty troughopposite the trough which contains the pre-conditioning solvent. 
Equilibration can be performed with any liquid and for any period of time. 
Start of development : It is started only when developing solvent is introduced into the trough 
with the plate.             
2.Automaticdeveloping chamber(ADC) In the ADC this step is fully automatic and 
independent ofenvironmental effects.The activity and pre-conditioning of the layer, chamber 
saturation,developing distance and final drying can be pre-setand automatically monitored by 
ADC. 
 
 
 
 
 
 
  
 
 
 
 
 
 
Fig545 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
            STEPS INVOLVED IN HPTLC METHOD DEVELOPMENT 
FIG 6
 
 
Selection Of ChromatographicLayer22 
 
Precoated plates - different support materials - different Sorbents available 
80% of analysis - silica gel GF · Basic substances, alkaloids and steroids – 
AluminumOxide,Amino acids, dipeptides, sugars and alkaloids - cellulose 
Non-polar substances, fatty acids, carotenoids, cholesterol - RP2, RP8 and RP18 
Preservatives, barbiturates, analgesic and phenothiazines- Hybrid plates-RPWF254 
 
 
 
 
 
  
 
 
Selection Of HPTLC Plates 
 
Previously hand made plates is used in TLC for both qualitative andquantitative work. 
Certain drawbacks with that is non-uniform layer, formation of thick layer paved for advent 
of precoated plates. 
Nowadays precoated plates are available in different format and thickness by various 
manufactures. Pre coated plates can be used for both qualitative and quantitative work 
in HPTLC.  
Glass plates 
Poly ester/polyethylene 
Aluminum plates 
Glass Plates 
Resistant to heat & Chemical  
Easy to handle 
 
                       Fig7 
Fragile 
High weight 
Higher production cost 
Fragile 
High weight 
Higher production 
 
  
 
 
 
Poly ester /Poly ethylene 
 Thickness of Plate 0.2 mm Figure-9 
It can be produced in Roll forms 
Unbreakable 
 Less packing material required 
 Development of plate can not be above temp. 1200 losses of it shape 
Aluminium plates 
 Thickness of Plate 0.1 mm 
 It can be produced in Roll forms 
Sorbents Used In HPTLC Plates 
Sorbent, which are used in conventional TLC, are also used in HPTLC with or 
without modification 
Silica gel 65F(modified) 
Highly purified Silica gel 60 
Aluminium oxide 
Cellulose Microcrystalline 
Slica gel 
Reversed stationary phase 
Hybrid Plates 
Particle SizeOf Sorbents 
Layer Thickness 
HPTLC 6μm, TLC 10μm. 
The layer of thickness in HPTLC is around 100-200 μm,where as 250μm in conventional 
TLC. 
Layer Pre -Washing 
Ascending method 
Dipping method 
Continuous method 
 
 
 
 
  
 
 Solvents used for pre washing 
Methanol (commonly used) 
Chloroform: Methanol: Ammonia (90:10:1) 
 Chloroform: Methanol (1:1) 
Methylene chloride: Methanol (1:1) 
 Ammonia solution (1%) 
Sample and Standard Preparation 
To avoid interference from impurities and water vapours 
Low signal to noise ratio - Straight base line- Improvement of LOD 
Solvents used are Methanol, Chloroform: Methanol (1:1), Ethyl acetate: Methanol 
(1:1), Chloroform: Methanol: Ammonia (90:!0:1), Methylene chloride : Methanol 
(1:1), 1% Ammonia or 1% Acetic acid 
Dry the plates and store in dust free atmosphere 
Sample Preparation 
Proper sample preparation is an  importantprereqisite for success of TLC separation. 
Besides maximizing the yield of analyte in selected solvent, stability of analyte during 
extraction and analysis must be considered. Therefore choice of suitable solvent for 
given analysis is very important. 
Solvent for dissolving sample should be non polar and volatile as far as possible, since polar 
solvents are likely to induces circular chromatogram at the origin. 
Activation Of Pre coated Plates 
The plates are activated by placing in an oven at 110-120°c for 30 min., this 
step will removes water that has been physically absorbed on surface at solvent layer. 
Freshly opened box of HPTLC plates usually does not require activation. Activation at 
highertemp.and for longer time is avoided which pleads to very active layer and there 
is risk of sample being decomposed. 
Application Of Sample And Standard Solution 
Sample application is one imp. And critical step for obtaining good resolution for 
quantification by HPTLC. Sample / std. Is applied as a sporty or band depending upon 
the analysis. 
 
 
 
 
  
 
Spot application is done by using 
Capillary tubes 
Micro bulb pipettes 
Micro syringes 
Automatic sample applicator 
Selection of mobile phase21 
 Trial and error 
one’s own experience and Literature 
Normal phase 
Stationary phase is polar. Mobile phase is nonpolar. Non-polar compounds eluted first 
because of lower affinity with stationaryphase.Polar compounds retained because of higher 
affinity with the stationary phase. 
Reversed phase 
Stationary phase is no polar. Mobile phase is polar 
Polar compounds eluted first because of lower affinity with stationary phase.Non-Polar 
compounds retained because of higher affinity with the stationary phase.3 - 4 component 
mobile phase should be avoided.Multi component mobile phase once used not recommended 
for further use andsolvent composition is expressed by volumes (v/v) and sum of volumes 
isusually 100. Twin trough chambers are used only 10 -15 ml of mobile phase is required. 
Components of mobile phase should be mixed introduced into the twin – troughchamber. 
Pre- conditioning (Chamber saturation) 
 Un- saturated chamber causes high Rf values. 
 Saturated chamber by lining with filter paper for 30 minutes prior to development -uniform 
distribution of solvent vapours - less solvent for the sample to travel - lower Rfvalues. 
Chromatographic development and drying 
After development, remove the plate and mobile phase is removed from the plate – toavoid 
contamination of lab atmosphere 
 Dry in vacuum desiccator - avoid hair drier - essential oil components may evaporate 
 
 
 
 
 
 
  
 
Chromatogram Development 
After application of sample in HPTLC plate, chromatogram is developed by dipping in 
suitable solvent system taken in a developing chamber. The solvent system is rises over 
the layer by capillary action and separation of sample in to different components takes 
Place. 
Selection of solvent system / mobile phase 
 Chamber saturation 
 Type of development and developing device. 
Linear & Radial Development 
In a close bed tec. Such as HPLC only Linear development 
Is possible, But an open bed tec. Like HPTLC does not suffer this limitation. 
HPTLC can develop by 
Ascending (linear ),Circular,Anti- circular 
Detection and visualization 
Detection under UV light is first choice - non destructive 
Spots of fluorescent compounds can be seen at 254 nm (short wave length) or at 366nm (long 
wave length) 
Spots of nonfluorescent compounds can be seen - fluorescent stationary phase is used -silica 
gel GF 
Non UV absorbing compounds like ethambutol, dicylomine etc. - dipping the plates in0.1% 
iodine solution 
When individual component does not respond to UV - derivatisation required fordetection 
There is no difficulty in detecting the colored substances or colorless substancesabsorbing 
UV-radiations or with fluoresce (Riboflavin) 
“Derivatisation” 
Detection of spots / bands are done by 
Destruction / Non-reverse 
Non-destructive / Reversible 
Miscellaneous methods 
 
 
 
 
  
 
 Quantification 
Sample and standard should be chromatographed on same plate - after development 
chromatogram is scanned 
Camag TLC scanner III scan the chromatogram in reflectance or in transmittance mode by 
absorbance or by fluorescent mode - scanning speed is selectable up to 100 mm/s - spectra 
recording is fast - 36 tracks with up to 100 peak windows can be evaluated. 
Calibration of single and multiple levels with linear or non-linear regressions are possible · 
When target values are to be verified such as stability testing and dissolution profile single 
level calibration is suitable Statistics such as RSD or CI report automatically 
Concentration of analyte in the sample is calculated by considering the sample 
initially taken and dilution factors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
VALIDATION 
Validation of an analytical method is the process by which it is estimated, bylaboratory 
studies, that the performance characteristics of the method meet therequirements for the 
intended analytical applications 28 
 
 REASONS FOR VALIDATION14.15 
1. Enables scientists to communicate scientifically and effectively on technical matters. 
2. Setting standards of evaluation procedures for checking complaints and taking remedial 
measures. 
3. Retrospective validation is useful for trend comparison of results compliance to 
cGMP/cGLP. 
4. Closer interaction with pharmacopoeia harmonization particularly in respect of impurities 
determination and their limits. 
5. For taking appropriate action in case of non – compliance. 
6. To provide high degree of confidence that the same level of quality is consistently built 
into each unit of finished product from batch to batch. 
7. Economic: The consistency and reliability of validated analytical procedure is to produce a 
quality product with all the quality attributes, thus providing indirect cost saving from 
reduced testing or re testing and elimination of product rejection. As quality control process 
is not static, 
 
SUMMARY OF VALIDATION PROCEDURE 
PARAMETERS USED FOR ASSAY VALIDATION:-7,24,25 
Specificity23 
Specificity is the ability to assess unequivocally the analyte in the presence ofcomponents 
which may be expected to be present. Lack of specificity of an individualanalytical procedure 
may be compensated by other supporting analytical procedures. 
 
Accuracy2 
The ICH defines the accuracy of an analytical procedure as the closeness of agreement 
between the values that are accepted either as conventional true values or an accepted 
reference value and the value found. 
  
 
 Accuracy is usually reported as percent recovery by assay, using the proposed analytical 
procedure, of known amount of analyte added to the sample. The ICH also recommended 
assessing a minimum of nine determinations over a minimum of three concentration levels 
covering the specified range (e.g., three concentrations/three replicates). 
 
Precision 
The precision of an analytical procedure expresses the closeness of agreementbetween a 
series of measurements obtained from multiple sampling of the samehomogenous sample 
under the prescribed conditions. Precision of an analyticalprocedure is usually expressed as 
the variance, standard deviation or coefficient of some form of validation . 
Precision is usually investigated at three levels: repeatability, intermediate precision, and  
reproducibility. 
 
Linearity27 
Linearity of an analytical procedure is its ability (within a given range) to obtain 
test results which are directly proportional to the concentration (amount) of analyte in 
the sample. 
 
Range 
Range of an analytical procedure is the interval between the upper and lower 
concentration (amount) of analyte in the sample (including these concentrations) for 
which it has been demonstrated that the analytical procedure has a suitable level of 
precision, accuracy and linearity. 
 
Robustness25 
  The robustness of an analytical procedure is a measure of  its capacity to remain unaffected 
by small but deliberate variations in the analytical procedure parameters. The robustness of 
the analytical procedure provides an indication of its reliability during normal use. The 
evaluation of robustness should be considered during development of the analytical 
procedure. Common variations that are investigated for robustness include filter effect, 
stability of analytical solutions, extraction time during sample preparation, pH variations in 
the mobile-phase composition, variations in mobile-phase composition, columns, temperature 
effect, and flow rate. 
 
  
 
Ruggedness16 
 It is defined as the reproducibility of  results when the method is performed under actual use 
conditions. This includes different analysts, laboratories, columns, instruments, sources of  
reagents, chemicals, solvents, and so on. Method  ruggedness may not be known when a 
method is first developed, but insight is obtained during subsequent use of that method.  
Detection limit 
The detection limit of an individual analytical procedure is the lowest amount of 
analyte in a sample which can be detected but not necessarily quantitated as an exact 
value. 
Based on the standard deviation of the response and the slope, the detection 
limit (DL) may be expressed 
DL=  3 σ 
           S  
Where 
σ = standard deviation of the response, 
S = slope of the calibration curve (of the analyte). 
Quantitation limit 
The quantitation limit of an analytical procedure is the lowest amount of analyte 
in a sample which can be quantitatively determined with suitable precision, accuracy,and 
reliability by the proposed method.   
Based on the standard deviation of the response and the slope, quantitation limit 
may be expressed as 
            10 σ 
QL=      S 
Where 
σ = standard deviation of the response, 
S = slope of the calibration curve ( of the analyte). 
System suitability testing 29 
System suitability is an integral part of many analytical procedures. The tests 
are based on the concept that the equipment, electronics, analytical operations and 
samples to be analyzed constitute an integral system that can be evaluated as such. 
 
 
 
  
 
The system suitability testing parameters established for the liquid 
chromatographic procedure are: 
Retention time (Rt) 
This is the time of emergence of the maximum of a component after injection. 
Symmetry factor (or) tailing factor (T) 
                        W0.05 
            T =        2f 
The assessment of peak shape is in terms of symmetry factor. 
 Number of theoretical plates (N) 
ۼ = ૞.૞૝ቆ ܜ܀
܅ܐ/૛ቇ
૛
 
The assessment of performance of efficient of a column is in terms of the 
number of theoretical plates. 
Resolution 
Resolution is a measure of the extent of separation of two components and the baseline 
separation achieved. Resolution is generally defined as “the distance between the 
centers of two eluting peaks as measured by retention time or volume divided by the 
average width of the respective peaks”. 
             2(t2-t1) 
R =      W2+W1 
Statistical parameters 
Statistics consist of a set of methods and rules for organizing and interpreting 
observations. 
The precision or reproducibility of the analytical method was determined by repeating 
the analysis six times and the following statistical parameters were calculated. 
The Formulas are   
                                 Σ( x – x)2 
Standard Deviation = n – 1 
 
R.S.D (%) = S.D X 100 
                          Mean 
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Drug profile 
 
 
Structure 
 
 
 
 
Chemical name  (2S,5R)-(3,3-dimethyl-4,4,7-trioxo-4-thia-1-
azabicyclo[3.2.0]hept 2ylcarbonyloxy) methyl 
(2S,5R,6R)-6-[(R)-2-Amino-2-phenylacetamido]-3,3-
dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-
carboxylate;Hydroxymethyl(+)-(2S,5R,6R)-6-[(R)-(2-
amino-2phenylacetamido)]-3,3-dimethyl-7-oxo-4-
thia-1-azabicyclo[3.2.0] heptane-2-
carboxylate,(2S,5R)-3,3-dimethyl-7oxo-4-thia-1-
azabicyclo[3.2.0]heptane-2 carboxylate 4,4 dioxide; 4 
methylbenzenesulphonic acid 
Molecular formula   C32H38N4O12S3 
Molecular weight                 766.85 g/mol 
Physical appearance   White to off whitecrystallinepowder 
 
 
  
 
Solubility    Practically insoluble in water, sparingly soluble in  
alcohol and soluble in methanol 
 Category   β-lactam Antibiotic  
 Mode of action  Sultamicillin has a wide spectrum of  activity 
 
 Spectrum of activity33,35,37,30 
Gram-positive bacteria Gram-negative bacteria Anaerobic bacteria 
Staphylococcus aureus      (β-
lactamase-producing   and non-
producing ) 
Haemophilusinfluenzae                 
(β-lactamase-producing and 
non-producing) 
Bacteroides species         
(including Bacteriodesfragilis) 
Staphylococcus epidermidis Moraxella catarrhalis Peptococcus species 
Streptococcus faecalis Escherichia coli Peptostreptococcus species 
Streptococcus pneumonia Klebsiella Clostridium species 
Streptococcus pyogenes Proteus mirabilis  
Streptococcus viridians Neisseria gonorrhoeae  
 Proteus vulgaris  
 Providencia rettgeri  
 Providencia stuartii  
 Morganellamorganii  
Table  4 
 
 
 
  
 
It is a prodrug of ampicillin and of the beta-lactamase inhibitor sulbactam; it consists of two 
compounds linked as a double ester.37During absorption from the gastrointestinal tract it is 
hydrolysed, releasing equimolar quantities of ampicillin and sulbactam. Provides high serum 
concentrations following IM and IV administration.Ampicillin is 28% reversibly bound to 
serum proteins and sulbactam is 38% reversibly bound 
Mechanism of action 31 
Sultamicillin is a combination of ampicillin and sulbactam. It exerts bactericidal effect by 
inhibiting bacterial wall mucopeptide biosynthesis mediated by the ampicillin and also by the 
irreversible β–lactamase inhibition by sulbactam in its formula. The addition of sulbactam to 
ampicillin extends the spectrum of ampicillin to include some β-lactamase producing 
organisms or some penicillin resistant species thereby inhibiting bacterial cell wall synthesis 
by binding to one or more of the penicillin binding proteins (PBPs) which in turn inhibits the 
final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting 
cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic 
enzymes like autolysins and murein hydrolases while cell wall assembly is arrested. 
Uses 
Skin and soft tissue infections.  
Intra-abdominal infections.  
Gynecological infections. 
Respiratory and urinary tract infections. 
Gonococcal infections.  
Bacterial septicemia. 
Bone and joint infections. 
Prophylaxis following abortion and cesarean section to decrease the risk of sepsis. 
 
  
 
Contraindications and Cautions 
Sultamicillin is contraindicated in individuals hypersensitive to penicillin’s and 
cephalosporins.Ampicillin should not be used in patients with infectious mononucleosis since 
the drug causes serious skin rashes in these cases. 
During prolonged treatment periods, vital organs functions including renal, hepatic and 
hematopoietic system should be monitored. Though ampicillin and sulbactam have no 
carcinogenic or mutagenic effects, its safety of administration in pregnant women has to be 
established. 
Development of super infection during administration should be considered and if it occurs 
treatment should be discontinued and necessary measures should be applied. 
Special precautions should be taken for neonates, pregnant women and lactating 
mothers.Caution should be taken for patients with impaired renal function and in patients 
suffering from hyperuricemia. 
Adverse effects 
Local (at the injection) Pain at the injection site and thrombophlebitis during IV 
administration. 
Gastrointestinal systemsevere nausea or vomiting, stomatitis, tongue discoloration, gastritis, 
diarrhea, enterocolitis and pseudomembranous colitis. 
Skin and soft tissue Skin rash, itching, utricaria, erythema multiformae and rarely exfoliative 
dermatitis and some hypersensitive reactions. 
HematologicalAgranulocytosis and decrease in hemoglobin, hematocrit, erythrocyte, 
leucocyte, lymphocyte and platelet or increase in lymphocyte, monocyte, eosinophilia and 
platelet; these findings are reversible and return to normal upon discontinuation of therapy. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                          
                          Literature review 
  
 
         Literature review on the analytical methods of Sultamicillin tosilate 
1. Friedel, Heather A et al.,(1989)presented a review on the anti-bacterial 
activity.Sultamicillin is the tosylate salt of the double ester of sulbactam plus ampicillin. 
Sulbactam is a semisynthetic [beta]-lactamase inhibitor. Previously the combination hs 
been using only in the parentral form now a days that has been extended to oral dosage 
also with the saeneffectas that of parentral one.Sultamicillin has been shown to be 
clinically effective in non-comparative trials in patients with infections of the respiratory 
tract, ears, nose and throat, urinary tract, skin and soft tissues, as well as in obstetric and 
gynaecological infections, and in the treatment of gonorrhoea. In a small number of 
controlled trials, sultamicillin has shown comparable clinical efficacy to phenoxymethyl 
penicillin (penicillin V) and to amoxycillin (alone and in combination with clavulanic 
acid) in the treatment of paediatric streptococcal pharyngitis and acute otitis media, 
respectively; to cefaclor in the treatment of acute otitis media in adults; and to 
bacampicillin, cloxacillin and flucloxacillin plus ampicillin in skin and soft tissue 
infections in adults, children and adult diabetic patients, respectively. Sultamicillin was 
superior in efficacy to bacampicillin in the treatment of chronic respiratory infections, to 
cefaclor in the treatment of acute otitis media in adults, and to cefadroxil in the treatment 
of patients with complicated urinary tract infections. However, in single-dose treatment of 
uncomplicated gonorrhoea, sultamicillin (1500mg plus probenecid 1g) was inferior to a 
2g intramuscular dose of spectinomycin. 
2. Airede.A.Ket al.,32(1996) presented a review on theuse of an effective antimicrobial 
remains a problem in the neonate, thereby necessitating empiric combinations of 
parenteral agents. We therefore studied oral Sultamicillin's (Unasyn CP-45 899) efficacy 
and tolerability (dose = 50 mg/kg per day) in the treatment of serious infections in 27 
neonates over an 18 month period. The study cohort comprised newborns with suspected 
or confirmed infections in the Special Care Baby Unit of a referral hospital. The infants 
with overwhelming/severe infections or proven/suspected renal, hepatic or hematologic 
disease; or known hypersensitivity to penicillins or any β-lactams were excluded. There 
were 12 babies with skin and soft-tissue infections, although pneumonia  was most 
predominant in our series. Bacterial isolates were mainly Staphylococcus aureus, 
Escherichia Coli and Klebsiellapneumoniae with a β-lactamase production rate of 88%. 
The clinical cure and improvement rates were 96.3 and 100%, respectively and the 
  
 
evaluable bacteriologic cure-rate was 93.8%. The mean (S.D.) duration of therapy was 
7.4 (2.6) days (range, 4–14) with significant resolution of features occurring within a 48 h 
period ( , P< 0.01). No serious adverse/side effects were seen as only one (3.7%) 
experienced mild loose stools. We show with these prospective observations (our cohort 
albeit small) that sultamicillin orally is efficacious, tolerable and safe for treating of mild 
to moderate infections in the newborn caused by both gram-positive and gram-negative 
pathogens. 
3. Changqin H et al.,33(1997) developed two reversed phase ion pair high performance 
liquid chromatography for the analysis of Sultamicillin with an ODS column or a CN 
column. The mobile phase was a combination of methanol and 0.018mol/l 
tetrabutylammonium hydroxide containing 0.4% of triethylamine whose pH was adjusted 
to 4.0 by phosphoric acid in the ratio (28:72) for ODS chromatographic system; and 
acetonitrile - 0.05mol/l tetrabutylammonium hydroxide aqueous solution pH adjusted to 
3.5 by phosphoric acid (1:99) in the CN column system. Both chromatographic systems 
have different characteristics. The ODS system is suitable for determination of the 
content of Sultamicillin in stability study and the CN column system is more suitable for 
tracing the changes of impurities in chemical study. Using both the chromatographic 
systems the stability of Sultamicillin in solution was studied and its degradation profile 
was discussed. 
  4    El-Shanawani  A.A34 .,(1998)developed a rapid, simple and sensitive method for HPLC 
determination of Sulbactam, SultamicillinTosylate, Cefaclor, Ampicillin and Cefoperazone in 
pharmaceutical preparations. The manufacture precursors like 6-aminopenicillanic acid 
(6APA) in ampicillin or 7-aminocephalosporanic acid (7ACA) in cefaclor and cefoperazone 
and the expected degradation products like phenylglycin in cefaclor and ampicillin or p-
hydroxyphenylglycin in cefoperazone do not interfere with the determination. The drugs were 
chromatographed on a Spherisorb ODS-2 column with 25% methanol in 0.005M 
tetramethylammonium hydroxide (TMAH) whose pH was adjusted to 3.4 with 1 M 
phosphoric acid as mobile phase and salicylamide was used as internal standard. The flow 
rate was 1 ml/min and detection at 230 nm. This method was applied to Unasyn vials and 
tablets, Cefobid vials and Ceclor capsules and packets. The relative standard deviation ranged 
from 1.23 to 2.22%.  
  
 
5   Pneumologie I et al.,35(2001)reported the emergence of beta-lactamase-mediated 
resistance to beta-lactam antibiotics among key respiratory tract pathogens has threatened the 
usefulness of the beta-lactam agents familiar to physicians as being clinically effective and 
well tolerated. This article reassesses the clinical usefulness of ampicillin when administered 
in combination with the beta-lactamase inhibitor sulbactam, either intravenously or orally (as 
the mutual prodrugsultamicillin), in the treatment of upper and lower respiratory tract 
infections. Numerous clinical studies and several meta-analyses indicate that 
ampicillin/sulbactam and sultamicillin are clinically effective and well tolerated in both 
adults and children. 
6.  Pajchel G et al.,36(2002) explained a micellarelectrokinetic capillaryelectrophoretic 
method for determination of Sultamicillin in Unasyn oral preparations like tablets and 
suspensions. Mobile phase used was phosphate-borate buffer containing 1.0% sodium 
dodecylsulfate with pH 7. The elaborated method ensures separation of Sultamicillin from p-
toulenesulphonic acid and impurities like ampicillin, sulbactam and penicillamine. The 
method was thoroughly validated and the linearity ranged from 0.05- 1.5 mg/ml.  
 
7.ZHang Qing  Yuan.,37(2004)   reported Sultamicillin is the tosilate salt of the double ester 
of sulbactum plus ampicillin. That is hydrolysed by enzymes in the intestinal wall after orally 
administered, releasing sulbactum and ampicillin in equimolar proportions. Sulbactum is an 
effective irreversible semisynthetic inhibitor unique for β- lactamase, when in combination 
with ampicillin, which extends the antibacterial activity of the latter including some β - 
lactamase - producing strains of bacteria that would otherwise be resistant. The antibacterial 
activity of sultamicillin against most of bacteria was 2 - 64 times stronger than that of 
ampicillin. A close relationship exists between the pharmacokinetic handling of both 
sulbactum and ampicillin. Both time to peak plasma concentration (approximate 1 hour) and 
profile of elimination are similar for two drugs. Sultamicillin had much higher bactericidal 
activity than that of ampicillin arid sulbactum(1 : 1). Sultamcillin has been shown to be 
clinically effective in non - comparative trials in patients with infection of the respiratory 
tract, nose and throat, urinary tract, shin and soft tissues, as in obstetric and gynecological 
infections and in the treatment of gonorrhea. The overall incidence of adverse reaction 
reported was 7.2% (3 005 cases), the typical symptoms with an incidence of greater than 1% 
was diarrhoea (3. 7% ) and soft stools (1. 1% ). 
  
 
8. Bhosleet al.,38(2006) presented a review article where they discussed the mutual prodrug 
concept and laid a great emphasis on research to discover methods aimed at improving the 
therapeutic efficacy of drug by minimizing or eliminating their undesirable properties. 
Mutual prodrug is a type of carrier-linked prodrug where the carrier is another biologically 
active drug instead of an inert molecule. Sultamicillin is a combination of Ampicillin and 
Sulbactam with synergistic action. In the design of Sultamicillin, the irreversible β-lactamase 
inhibitor Sulbactam with very limited antibacterial activity when combined chemically via 
ester linkage with Ampicillin enhanced its activity both invivo and invitro. Upon oral 
administration Sultamicillin is completely hydrolysed to equimolar proportions of ampicillin 
and sulbactam thus forming an efficient prodrug.Sultamicillin results in more efficient oral 
absorption than its single agent does. Peak serum concentrations of ampicillin achieved are 
approximately 3.5 fold those obtained with equivalent amount of oral ampicillin. The 
pharmacokinetic parameters of the two components are similar, both being eliminated 
primarily by renal excretion. Although the elimination half-lives of both are approximately 1 
hr, the high serum concentration achieved coupled with their synergistic activity permit twice 
daily dosing. One more advantage presented by sultamicillin is that even though most β-
lactamase resistant antimicrobials must be given parenterally, sultamicillin is given by mouth. 
It has been found to be effective against skeletal infections in children, urinary infections in 
geriatric patients and uncomplicated gonorrhea. 
 
9. H. J. Rogers et al39., (2009) carried out pharmacokinetic and bioavailability studies of 
Sultamicillin and estimated it by HPLC. An HPLC assay for sulbactam in plasma, saliva and 
urine was used to determine the absolute bioavailability of sulbactam and ampicillin from 
sultamicillin in six normal male volunteers who each received a single oral dose of 750 mg of 
sultamicillin or iv dose of equivalent amount of ampicillin (441 mg) and sulbactam (294 mg). 
Treatment was given in random order with not less than four days intervening. The mean 
peak concentrations and time to peak of sulbactam and ampicillin following the 750 mg oral 
dose of sultamicillin were 8-9 and 91 mg/l and 0-96 and 0-92 h respectively. The half-lives, 
systemic and renal clearances for sulbactam and ampicillin were similar.  The bioavailability 
for both drugs from sultamicillin as estimated from both plasma and urine pharmacokinetics 
was better than 80%. Thus they concluded that sultamicillin is a very efficient prodrug for 
ampicillin and sulbactam and that the HPLC method was accurate, rapid and easier to 
perform. 
 
  
 
10 .Mustafa Polaet al.,40(2009) conducted an electron spin study to study parameters like 
radiation sensitivity and dosimetric features of Sultamicillin tosylate.  Classic sterilization 
techniques when used leads to serious degradations especially for temperature sensitive drug. 
However the use of high energy radiation such as gamma rays for sterilization offers clear 
advantages but radiosensitivity of irradiated pharmaceuticals is an important aspect. This 
potential of radiosensitivity made Sultamicillin to be used as dosimetric material and it was 
investigated by electron spin resonance spectroscopy. 
11.Schutz.,41(2009) detailed the efficacy and safety of Sultamicillin in an open randomized 
multicentric study of two aminopenicillin/β-lactamase inhibitor combinations for oral 
administration ie; a comparision between Sultamicillin (750 mg bid) and 
amoxicillin/clavulanate (625 mg tid) in 132 patients with uncomplicated urinary tract 
infections. Both combinations were well tolerated and troublesome adverse effects were not 
seen. The patients were divided into two groups and one received Sultamicillin and the other 
a combination of amoxyillin and clavulanate. In the Sultamicillin group 95.3% were treated 
successfully whereas in amoxicillin/clavulanate it was 90.3%; thus proving sultamicillin 
more efficacious. Moreover Sultamicillin has the advantage of only twice-daily dosing.    
between 0.1-1.1 mg/l.     
12. V J Kumar, P B Gupta et al42.,(2011)found a new degradant substance during gradient 
reverse phase HPLC analysis of stability storage samples. This method is also used for 
identification, isolation and characterization of the new degradant. The level of the degradant 
impurity was observed up to 1.0%. The impurity was identified by LC –MS and was 
characterized by H- NMR, C-NMR, 2D-NMR, LC/MS/MS, MS/TOF, elemental analysis and 
IR. The impurity identified was formaldehyde adduct with 5-oxo-4-phenylimidazolidin-1-yl 
moiety which was later prepared by isolation and co-injected into column to confirm 
retention time. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                
                Aim and plan of work 
  
 
                                         AIM AND PLAN OF WORK 
 
AIM 
To develop and validate a new isocratic RP-HPLC and HPTLC methods for the 
determination of sultamcillin tosylate in tablet dosage form. 
To validate the method with respect to linearity, precision, accuracy and robustness. 
To develop the method suitable for routine analysis of sultamcillin tosylate in pharmaceutical 
formulation. 
OBJECTIVE 
The objective of validation of an analytical procedure is to demonstrate that it is suitable for 
its intended purpose. 
PLAN OF WORK 
1. Solubility data,analytical data is to be studied to develop the initial conditions. 
2. Selection of initial separation conditions and trails for assay of sultamcillin tosylate  
in pharmaceutical dosage form. 
3. To develop a method for the assay of sultamcillin tosylate  in pure and marketed 
sample by RP-HPLC and HPTLC. 
To validate the developed assay method according to ICH method validation parameters 
such as system suitability, linearity, precision, accuracy, robustness,etc 
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                                 MATERIALS AND INSTRUMENTS 
 
MATERIALS AND METHODS    
1) Balance (Ascoset, model ER200A) 
2) pH meter(ADWA,modelAD1020) 
3) HPLC- Shimadzu prominence2010 
4) Detector-UV-VIS detector 
5) Chromatographic data software-spectrum ES 
6) Column- kromasil100 ,C-18 (4.6mmx 3.5µ) 
Reagents and chemicals 
1) Methanol (HPLC grade)-Merck 
2) Purified water(HPLC grade)- Millipore 
3) Ortho phosphoric acid(AR grade)- Rankem 
4)Sodiumdihydrogenortho phosphate dehydrate (AR garde) 
5) Acetonitrile  (HPLC grade) 
          SULTAMCILLIN TOSYLATE- Working standard 
    SULTAMCILLIN TABLET- 500mg 
 
 
 
 
 
 
 
 
  
 
    METHOD DEVELOPMENT AND OPTIMIZATION 
                               Chromatographic conditions 
Table 5 
 
Instrument  Shimadzu 2010 prominence 
Column Kromasil C18,3.5µ(100mm×4.6mm) 
Buffer phosphate buffer solution pH 3 
Flow rate 1.0ml/min. 
Wavelength 215 nm 
Injection volume 10µl 
Column temperature 25 
Runtime 20minutes 
Mobile phase Acetonitrile: phosphate buffer(20:80) 
Elution technique isocratic 
MOBILE PHASE PREPARATION:-   
Acetonitrile hplc grade 
 Phosphate buffer solution:- 
About 4.68 g of Sodium dihydrogenortho phosphate dihydrate was dissolved in 1 litre                                           
of water and sonicated for a period of 5 minutes and then pH of the solution was adjusted to 3 
+ 0.05 using orthophosphoric acid. The buffer was filtered through a 0.45 m membrane 
filter.  
The ratio of mobile phase is (buffer) 80: (Acetonitrile)20. 
 
 
  
 
Diluent:  
Mobile phase is used as diluent. 
Standard preparation 
Accurately weighed 50mg of sultamcillin tosylate WS in 100 ml volumetric flask and 50 ml 
of diluent was added. Sonicated to dissolve and made up the volume with diluent. Pipetted 
out 5ml of above solution in 100ml volumetric flask and make up the volume with diluent. 
Sample preparation 
Weighed 20 tablets crush and accurately weighed100mg equ. of sultamcillin tosylate  in 
200ml volumetric  flask and100ml of diluent was added,sonicated for 20 minutes and make 
up the volume with diluent.  Pipetted   5ml ofabove solution in 100ml volumetric flask and 
make up the volume with diluent. 
  
 
 
  
 
 
 
 
CHROMATOGRAM-1 
  
 
 
 
 
 
CHROMATOGRAM-2 
 
 
  
 
 
Assay % =                            
    AS       Wt.std      Dil.s  %.std       Avg. Wt. 
 -------------- x ----------x --------- x ----------x------------------ X 100 
    AStd           Dil.std     Wt.s        100              LC 
 Where: As = average area of sample preparation. 
            Astd= average area of standard preparation. 
 Wt.Std = Weight of working standard taken in mg. 
 %std    = Percentage purity of working standard  
LC =Label claim of sultamcillin tosilate 
             Wt.s=   weight of sample 
              Dil.s = dilution factor of sample 
              Dil.std = dilution factor of standard 
                           Validation of the analytical method 
The validation protocol is applicable to quantitative analytical method – assay, which is 
used for the estimation of active content in support of regulatory requirements. This 
procedure covers the following validation parameters. 
1)System Suitability 
2)Specificity 
3)Linearity and  
4)Accuracy 
5)Precision 
System precision/Reproducibility 
Method Precision/ Repeatability 
6)Robustness 
7)Solution stability 
 
 
  
 
SYSTEM SUITABILITY:- 
 Standard Preparation 
 
 Weighed accurately 50mg of sultamcillin tosilate WS in 100 ml volumetric flask and 50 ml  
of diluent was added and sonicate to dissolve and make up the volume with diluent. Pipetted    
5ml of above solution in 100ml volumetric flask and make up the volume with diluent. 
 
  Procedure 
 Injected 10μl of sultamcillin tosilate in replicate (5 times) and recorded the peak area 
response of sultamcillin tosilate. Calculated the % RSD for the response of the standard 
solution (for 5 replicates). 
 
 
 
Table 6  System suitability for sultamcillin tosilate 
Injection 
No. 
Response Theoretical Plate  Tailing Factor 
1 5297131 5253 1.10 
2 5276193 5264 1.11 
3 5304785 5264 1.12 
4 5303020 5207 1.10 
5 5355219               5253 1.10 
Average 5307270 5248.2 1.10 
StdDev 29120.11   
RSD 0.54   
 
 
 
  
 
TABLE 7 
                                   Parameter          Sultamcillin 
Retention time(min.) 9.06 
Tailing Factor 1.10 
Number of Theoretical Plates 5248.2 
Acceptance criteria 
The % RSD should not be more than 2.0%, USP tailing should not be more than 2.5, and 
Theoretical plates should not be less than 1500. 
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CHROMATOGRAM-7 
 
 
  
 
SPECIFICITY 
  Specificity is the ability to assess unequivocally the analyte in the presence of components 
that may be expected to be present such as the impurities, degradation products and matrix 
components.. 
Preparation of standard solution 
Weighed accurately 50mg of sultamcillin tosilateWS in 100 ml volumetric flask and 50 ml 
of diluent  was added and sonicated to dissolve and make up the volume with diluent. 
Pipetted 5ml of above solution in 100ml volumetric flask and make up the volume with 
diluent. 
Preparation of sample solution 
 Weighed 20 tablet crush, weighed accurately 100mg equ. of sultamcillin tosilate in 200ml 
volumetric flask  and added 100ml of diluent sonicate for 20 minutes and make up the 
volume with diluent. Pipette 5ml of above solution in 100ml volumetric flask and make up 
the volume with diluent. 
Preparation of placebo solution 
 Weighed 124 mg of placebo into 100 ml flask, add 50 ml of diluent sonicate and make up the 
volume with diluent. Pipetted 5ml of above solution in 100ml volumetric flask and make up 
the volume with diluent 
Procedure 
The sample is injected in the order Blank, Standard, Sample, and recorded the 
chromatograms.The data shall be evaluated for any interference from the blank and placebo. 
 
 
Acceptance criteria                    There should not be any interference due 
 
to placebo in sample and standard preparation. 
 
ConclusionArea due to placebo is Nil. Hence complies. 
 
 
  
 
CHROMATOGRAM-8 
  
 
CHROMATOGRAM-9 
  
 
CHROMATOGRAM-10
  
 
CHROMATOGRAM-11
  
 
 CHROMATOGRAM -12 
 
 
 
  
 
Linearity  
The linearity of an analytical procedure is its ability to elicit test results that are directly, or by 
a well – defined mathematical transformation, proportional to the concentration of analyte in 
samples within a given range.                                                                                                                                                 
Preparation of linearity stock solute 
 Weighed accurately 50 mg of sultamcillin tosylate WS into 200ml flask, Dissolved and make 
up the volume with diluent. 
Level 1 solution (50 %)Pipetted out 5 ml of the linearity stock solution into a 100ml 
standard flask and make up the volume with diluent. 
Level 2 solution (75 %) 
 Pipetted out 15 ml of the linearity stock solution into a 200ml ml standard flask and make up 
the volume with diluent 
Level 3 solution (100 %) 
   Pipetted out 5 ml of the linearity stock solution into a 50ml standard flask and make up the 
volume with diluent 
Level 4 solution (125 %) 
Pipetted out 25 ml of the linearity stock solution into a 200ml standard flask and make up the 
volume with diluent 
Level 5 solution (150 %) 
 Pipetted out 15 ml of the linearity stock solution into a 100ml ml standard flask make 
uptothe  volume with diluent. 
Plot the linearity curve of the standard solution response against the respective concentration.                             
 
 
 
 
 
 
  
 
Table 8   Linearity concentration range 
Linearity Solution Working Concentration (mcg/ml) 
Level 1 
 
12.50 
Level 2 
 
18.75 
Level 3 
 
25.00 
Level 4 
 
31.25 
Level 5 
 
27.50 
 
                                                                    Table-9                              
 
 
 
 
 
 
                                                                      FIG-8 
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Concentration (µg/ml)
LINEARITY
% Con(mcg/ml) 
Average 
Response 
50 12.5 2761181 
75 18.75 4148018 
100 25 5466784 
125 31.25 6688020 
150 37.5 8048904 
  
 
 
CHROMATOGRAM-13
  
 
CHROMATOGRAM-14
  
 
CHROMATOGRAM-15
  
 
CHROMATOGRAM-16 
 
  
 
CHROMATOGRAM-17 
 
 
 
 
  
 
Target Level (%) Conc. (μg /ml) Response Average Response 
50 12.5 
2724934 
2761181 2843854 
2714756 
75 18.75 
4115715 
4148018 4113625 
4214714 
100 25 
5437000 
5466784 5528142 
5435210 
125 31.25 
6717660 
6688620 6718654 
6629546 
150 37.5 
8021116 
8048904 8022121 
8103476 
Correlation Coefficient (r2) 0.9996 
                                                                      Table 10 
Acceptance criteria 
The linearity regression should not be less than 0.99. 
 
 
 
 
  
 
 
Accuracy:-  
The accuracy of an analytical procedure is the closeness of test results obtained by that 
procedure to the true value. The accuracy of analytical should be established across its 
range. 
Standard Stock Preparation 
Weighed  accurately 500mg of sultamcillin tosilate WS into 250 ml flask, Dissolved and 
diluted to volume with diluent.  Three standard stock solution as A, B and C was prepared. 
Solution A of 80 % concentration 
Pipettedout 20 ml of the stock solution and 124 mg of Placebo into a 100 ml standard flask 
and make up the volume with diluent. Pipettedout 5ml of above solution in 100ml volumetric 
flask and make up the volume with diluent. Repeat for Solution B and Solution C. 
Solution A of 100 % concentration 
Pipetted  out 25 ml of the stock solution and 124 mg of Placebo into a 100 ml standard flask 
and make up the volume with diluent. Pipetted  out 5ml of above solution in 100ml 
volumetric flask and make up the volume with diluent. Repeat for Solution B and Solution 
C. 
Solution A of 120 % concentration 
Pipettedout 30 ml of the stock solution and 124 mg of Placebo into a 100 ml standard flask 
and make up the volume with diluent. Pipetted  out 5ml of above solution in 100ml 
volumetric flask and make up the volume with diluent. Repeat for Solution B and Solution C 
Procedure 
Placebo is prepared based on the manufacturing formula and known concentrations of the 
standard solutions of 80%, 100% and 120% working concentrations was spiked and 
estimated for  recovery. 
 
 
 
 
 
  
 
 
 
Table11  Accuracy for sultamcillin tosilate 
 
Amount of 
Known std added 
with placebo 
(in %) 
 
Level 
 
Mean area 
 
Recovery 
(in %) 
 
Average recovery 
 
80% 
A 4896129 100.23 
99.78 B 4848960 99.88 
C 4887599 99.24 
 
100% 
A 5868406 101.44 
100.90 B 5823606 101.12 
C 5821200 100.13 
120% 
A 6748977 101.08 
100.41 B 6745252 99.91 
C 6665533 100.24 
Average  100.36 
  
Acceptance criterion 
The accuracy should be between 98 – 102%. 
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CHROMATOGRAM-23 
 
 
 
 
  
 
SYSTEM PRECISION 
Standard Preparation 
 Weigh accurately 50mg of sultamcillin WS in 100 ml volumetric flask add 50 ml of diluent 
sonicate to dissolve and make up the volume with diluent. Pipette 5ml of above solution in 
100ml volumetric flask and make up the volume with diluent. 
Table.no-12 
                  Sample               Concentration 
                    (µg/ml) 
                        Area 
1      Standard-injection                  100mcg/ml                5202029      
2      Standard-injection                 100mcg/ml                5199530 
3     Standard-injection                  100mcg/ml                5194871 
4     Standard-injection                  100mcg/ml               5205656 
5     Standard-injection                  100mcg/ml               5208263       
6     Standard-injection                  100mcg/ml               5182510 
 MEAN             5198809.83         
 STANDARD 
DEVIATION 
  9255.4093          
 RSD %              0.17 
 
Acceptance criteria 
RSD is not more than 2.0% 
Conclusion 
The precision determined in the above study reveals the reproducibility in the area & the 
RSD is 0.17 %.Therefore complies.       
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CHROMATOGRAM-29 
 
 
 
  
 
METHOD PRECISION 
Standard Preparation 
Weighedaccurately  50mg of sultamcillin tosilate WS in 100 ml volumetric flask add 50ml of 
diluent sonicate to dissolve and make up the volume with diluent. Pipetted 5ml of above 
solution in 100ml volumetric flask and make up the volume with diluent. 
Sample Preparation  
Weighed 20 tablet crush, weighed accurately 100mg equ. of sultamcillin tosilate  in 200ml 
volumetric flask add 100ml of diluent sonicate for 20 minutes and make up the volume with 
diluent. Pipette 5ml of above solution in 100ml volumetric flask and make up the volume 
with diluent. 
Procedure 
 Injected 10μl of in replicate (6 times) and recorded the peak area response and calculate. 
Calculated the assay or recovery value of the sample from each preparation and the % RSD 
of assay of the sample for all the 6 preparations. 
Weight of Sample 1 141.87 mg 
Weight of Sample 2 141.90mg 
Weight of Sample 3 142.05mg 
Weight of Sample 4141.89mg 
Weight of Sample 5   141.85 mg 
Weight of Sample 6    141.79 mg 
 
Acceptance criterion 
The % RSD of the assay or recovery value of the sultamcillin tosilatefor 6 sample 
preparations should not be more than 2.00. 
 
 
 
  
 
Table -13 
Method precision for sultamcillin tosilate 
Sample No. 
Response Average Response % Assay 
1 
5332627 
5284199 97.46 
5235771 
2 
5343184 
5341078 98.48 
5338972 
3 
5364140 
5410685 99.66 
5457230 
4 
5329675 
5329320 98.26 
5328965 
5 
         5345342 
5396593.5 99.54 
5447845 
6 
5372840 
5368380                99.06  
5363920 
Average 98.74 
StdDev 0.83966 
% RSD 0.8507 
  
 
CHROMATOGRAM-30
  
 
CHROMATOGRAM-31
  
 
CHROMATOGRAM-32
  
 
CHROMATOGRAM-33
  
 
CHROMATOGRAM-34
  
 
 
 
 
CHROMATOGRAM-35 
 
 
  
 
Robustness 
Change of wave length (±2.0 nm) 
Six sample preparation of Method precision shall be measured at two different wavelengths 
using UV-VIS Detector (213 and 217 nm).Calculate the assay or recovery value of the 
sample from each preparation and the % RSD of assay of the sample for all the 6 preparation 
 
Table  14 
Inj                         AT 213nm                       AT 217nm 
       Response        %Purity        Response       %Purity 
1 5328739 98.26 5419405 99.93 
2 5344824 100.40 5392517 99.44 
3 5307280 98.87 5434544 100.21 
4 5412432 99.86 5395316 99.49 
5 5354199 98.73 5338899 98.45 
6 5374850 99.11 5374850 100.76 
Average 99.205 99.623 
Std.deviation 0.78701 0.78978 
%RSD 0.7933 0.7927 
 
Acceptance criterion 
  The % RSD should not be more than 5.00. 
 
  
 
 
 
CHROMATOGRAM-36 
  
 
CHROMATOGRAM-37
  
 
CHROMATOGRAM-38
  
 
 
 
 
CHROMATOGRAM-39 
 
 
  
 
Solution stability:- 
Solution stability of Sultamicillin at bench top and in refrigerated condition over a period of 
few hours was studied by injecting test solutions at regular intervals of one hour as per test 
method. The solution prepared for system precision is used. 
Acceptance Criteria 
The solution is said to be stable if the % variability of the assay value does not exceed by1.5 
with that of initial. Hence the Bench top solution should be used within 4 hours and 
refrigerated solution can be used within 11 hours. 
 
 
Time in hours 
Bench top stability  (25ºC ) Refrigerated Condition (4-6 ºC) 
Response Area % %variability Response Area % % variability 
Initial 5314076   5366674   
1 5311386 99.95 0.05 5363788 99.95 0.05 
2 5306941 99.87 0.13 5355219 99.79 0.21 
3 5257571 98.94 1.06 5350625 99.70 0.30 
4 5232383 98.46 1.54* 5331925 99.35 0.65 
5 5165822 97.21 2.79 5320804 99.15 0.85 
6 5098639 95.95 4.05 5313440 99.00 0.99 
7 5063835 95.29 4.71 5304785 98.85 1.15 
8    5303020 98.81 1.18 
9    5301082 98.78 1.22 
10    5298173 98.72 1.27 
11    5297131 98.70 1.30* 
12    5276193 98.31 1.69 
Table:-15 
  
 
CHROMATOGRAM-40
  
 
              CHROMATOGRAM-41
  
 
CHROMATOGRAM-42
  
 
CHROMATOGRAM-43
  
 
CHROMATOGRAM-44
  
 
CHROMATOGRAM-45
  
 
CHROMATOGRAM-46 
 
 
 
 
 
  
 
                                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             Results and discussion 
  
 
                 RESULTS AND DISCUSSION 
 
The working conditions for the HPLC method was established for sultamcillin tosilate  and 
then applied on pharmaceutical dosage forms. 
 
Various mobile phase systems were prepared and used.   Phosphate buffer : Acetonitrile in 
the ratio of  20 : 80gave the better  resolution and sensitivity. 
 
The detection was carried out by using UV-visible detector at 215nm.Among the several flow 
rates tested (0.5-2.0), the flow rate of 1.0ml/min ml was the best for the drug with respect to 
location and resolution of analytical peaks. 
 
The retention time is 9.05min for sultamcillin tosylate. The number of theoretical plates was 
found to be 5248.20 for sultamcillin tosylate which indicates the symmetrical nature of  the 
peak. The retention time for the drug was found to be 0-9 minutes. This parameter represents 
the specificity of the method. 
 
System suitability parameters such as tailing factor, capacity factor, resolution and number of 
theoretical plates were calculated and the results are tabulated in table-5,6 and supported by 
the chromatogram-3 to 7. 
 
From the linearity studies, the specified concentration range was determined. It was observed 
that sultamcillin tosylate  is linear in the range of  50-150 % for the target concentrations. The 
linearity range of 12.5-37.5μg/ml for sultamcillin tosylate found to obey the linearity with the 
correlation coefficient of 0.9996. The linearity curve for sultamcilllintosylate were shown in 
the figure-8. The results of analytical  performance parameters were tabulated in table-8,9,10. 
 
 
The validation of the proposed method was verified by system precision and  method 
precision. The %RSD for  system precision and  method precision of sultamcillin tosylate 
was 0.17,0.8507 respectively.  
The validation of the proposed method was verified by recovery studies. The percentage 
recovery range was found to be satisfied which is represented in the table-13. 
 
  
 
The robustness studies were performed by changing wavelength and reports shown in the 
table-14. 
The validation of the proposed method was also verified by solution stability which is 
represented-15 
 
All the parameters including flow rate, temperature, detection wavelength and sensitivity 
were maintained constant throughout the procedure except for robustness studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
                              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             Materials and Methods     
                                   for Hptlc 
  
 
             HIGH PERFORMANCE THIN LAYER          
                                             CHROMATOGRAPHY 
 
Instrumentation 
Name of sample applicator:    Linomat ΙV with CAMAG 100µl syringe 
Scanner name                      : CAMAG TLC scanner ΙΙΙ 
Software used                      : WINCATS 
Chamber                              : CAMAG twin trough chamber (20X10) 
Stationary phase                  : TLC silica gel 60 F254   
Mobile phase                       :  Acetonitrile: Methanol: Water (3.5:5:1.5 v/v/v) 
Development time               : 20mints 
Development temperature   : ambient 
Detection                             : 215nm 
Diluents                               : Methanol 
 
Method development and optimization 
    Trial1 - methanol: acetone: ethyl acetate (5:2.5:2.5) 
    Trial2 –  n-butanol: ethanol (1:1) 
    Trial 3- n-butanol: ethyl acetate: water (4:4:2) 
    Trial 4 – acetonitrile: ethyl acetate: methanol (4:4:2) 
    Trial 5 – ethyl acetate: methanol: water (2:0.5:7) 
    Trial 6- Acetonitrile: methanol: Water (3.5:5:1.5 v/v/v) 
 
Out of the 6 trial made in the lab, the 6th trial was selected for further studies because when 
compare to other trials 6th trial was found to be the best one . 
 
 
 
  
 
 Standard Solution 
Weighed accurately 100 mg of sultamcillin  tosilate into 100 ml standard flask, dissolved and 
diluted to volume with methanol. 
 
Sample Preparation 
Weighed and crushed 20 tablets, weigh blend equivalent to 100mg of sultamcillin tosilate 
into a 100 ml volumetric flask, sonicated for 30 minutes and made it up to the mark with 
methanol.  
 
The percentage of drug content can be calculated using the given formula, 
 
% Drug content =Sample area x STD D.F. x Avg. wt. x  100 
                                 Std. area              SPL D.F            LC 
Where, 
   STD D.F   = Standard dilution factor 
   SPL D.F    = Sample dilution factor 
   L C            = Label claim 
  
 
 
 
 
Chromatogram-47(blank) 
  
 
 
 
 
       Chromatogram-48(standard) 
 
  
 
 
  
 
 
 
 
                                             Chromatogram-49(sample) 
  
  
 
 
 
                       HPTLC densitogram For Assay of sultamcillin tosilate 
 
 
 
 
 
 
 
 
 
 
  
 
Table  16 Assay of sultamcillin tosilate 
 
  Sample 
concentration 
(µg/spot) 
 
 
 Peak         
area 
 
Standard 
concentration 
(µg/spot) 
 
 
 
Peak 
area 
 
 
Amount 
(µg/spot) 
 
 
% purity 
3 2329.9 
 
3 2338.9 
 
39.8563978 
 
99.61754393 
 
3 2328.6 
 
3 2338.9 
 
39.70350789 
 
99.56196094 
 
3 2331.9 
 
3 2338.9 
 
39.85282561 
 
99.70305622 
 
 
Conclusion The estimated percentage purity was found to be close to 100% which prove the 
accuracy of the method. 
LINEARITY 
The response for the drug was linear (R2= 0.9963) in the concentration range between 1-6 
mcg/spot. The mean (±RSD) values of slope, intercept and correlation coefficient were 
726.25 (±1.53) and 120.71 (±0.856) and 0.9963 (±0.236), respectively. 
 
 
HPTLC for sultamcillintosilate    LINEARITY-1(FIG-9) 
 
y = 719.87x + 116.3
R² = 0.9967
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               HPTLC  for sultamcillin tosilate     LINEARITY-2 (FIG-10) 
 
 
 
 
                 HPTLC for sultamcillin tosilate   LINEARITY-3(FIG-11) 
 
  
y = 729.57x + 123.75
R² = 0.9963
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
0 1 2 3 4 5 6 7
y = 729.27x + 122.04
R² = 0.996
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       Chromatogram-50                       Chromatogram-51 
 
     Chromatogram-52                       Chromatogram-53 
 
     Chromatogram-54                          Chromatogram-55 
                              Linearity chromatograms 
 
  
  
 
 
 
 
                                  HPTLC densitogram- for linearity 
  
  
 
                                                           Linearity data of the method 
                                                                         Table 17 
Concentration(µg/spot) 
 
      Peak area Peak area Peak area Rf value 
 
0 0 0 0 0 
 
1 859 875 865.2 0.68 
 
2 1608.6 16745.5 1645.2 0.65 
 
3 2243.2 2345.2 2375.5 0.66 
 
4 3075.7 3085.2 3105.5 0.65 
 
5 3741.4 3854.7 3842.5 0.65 
 
6 4332.5 4352.6 4334.9 0.65 
        
         
         
         
         
         
         
y= mx   +  c 
 where, 
 y= correlation 
coefficient 
m= slope 
c=intercept 
         
 
 
 
 
 
  
 
Linearity parameters of sultamcillin tosilate  
Table 18 
Linearity Correlation 
coefficient(y) 
Slope(m) 
 
Intercept(c) 
Linearity 1 0.9967  
719.91 
116.34 
Linearity 2 0.9963  
729.57 
123.75 
Linearity 3 0.9960  
729.27 
122.04 
Average 0.9963  
726.25 
120.71 
                                                                                                                   
Std. deviation 
 
3.87791 
 
Acceptance criteria: The Linear Regression coefficient should not be less than 0.97 
Conclusion: The linearity study reveals that the concentration is linear in the range of   1-6 
mcg/spot. The linear coefficient is 0.9963. Hence complies. 
LIMIT OF DETECTION 
LOD=3.3× Std. Deviation/Average Slope 
        =0.0177µg/spot 
LIMIT OF QUANTITATION 
LOQ=10× Std. Deviation/Average Slope 
       =0.05368µg/spot 
 
 
 
 
 
 
 
 
  
 
PRECISION                                                      
                                              Table-19(Precision for Sultamcillintosilate) 
 
       concentration 
Inter assay                                       Intra assay 
 
Day 1 Day 1 Day 2 
 
Precision 1  Precision 2  Precision 3 
 
3µg/Spot 2338.9 2334.5 2368.2 
 
3µg/Spot 2334.2 2341.2 2334.2 
 
3µg/Spot 2312.5 2354.1 2345.9 
 
3µg/Spot 2335.2 2337.5 2387.2 
 
3µg/Spot 2342 2354.6 2341.2 
3µg/Spot 2335.4 2324.2 2355.9 
Mean 2333.0333 2341.0166 2355.4333 
 
SD 10.46989 11.7758 19.57883 
 
%RSD 0.4487 0.5030 0.8399 
 
       
 
     
       
     
      
      
      
 
 
 
     
      
      
       
       
  
 
 
Precision-1 
Chromatogram-56 
 
Precision-2 
Chromatogram-57 
 
 
  
 
                       Precision-3 
                       Chromatogram-58 
 
Precision-4 
Chromatogram-5 
 
  
 
 
Precision-5 
                                                    Chromatogram-60 
 
 
Acceptance criterion: The % RSD calculated must not be more than 2.00.  
Conclusion: The Standard deviation, Relative Standard deviation and Standard error were 
found to be low for  the  drug and hence prove that the method is precise. 
  
  
 
Accuracy:- 
 
 
 
 
 
 
HPTLC  densitogram for accuracy 
 
 
 
 
  
 
 
Table-20 (Accuracy for  sultamcillin tosilate) 
Sample 
concentration(µg/spot)
  
Peak 
area 
Standard 
concentration 
(µg/spot) 
Peak 
area 
Amount 
found 
Percentage 
found 
Average 
 
2 1680.6 
 
2 3901 
 
100.77519 
 
100.775 
 
 
 
100.0853 
 
 
2 1675.2 
 
2 3986.3 
 
99.7942 
 
99.794 
 
2 1672.4 
 
2 3975.1 
 
99.68705 
 
99.687 
 
3 2324.5 
 
3 5549.1 
 
100.13552 
 
100.135 
 
 
 
99.832 
 
 
3 2345.6 
 
3 5534.9 
 
99.67407 
 
99.674 
 
3 2341.9 
 
3 5498.8 
 
99.26042 
 
99.260 
 
4 3105.6 
 
4 7286.6 
 
100.30632 
 
100.306 
 
 
 
 
100.0773 
 
4 3101.1 
 
4 7445 
 
100.28475 
 
100.284 
 
4 3098.5 
 
4 7478.7 
 
99.64272 
 
99.642 
 
 
 
Conclusion: The estimated percentage purity was found to be close to 100% which prove the  
 
accuracy of the method. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Accuracy-1 
Chromatogram-61 
Accuracy-2 
Chromatogram-62 
 
 
  
 
 
 
 
  
 
Accuracy-3 
Chromatogram-63 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
RECOVERY 
Table-21(Recovery for sultamcillin tosilate) 
 
S.No 
Amount 
present 
(mcg/spot) 
Amount 
added 
(mcg/spot) Area 
Amount 
found 
(mcg/spot) 
% 
recovered 
1 1 0 
        857 
1.022706385 
 
102.27064 
 
2 1 1 
1674.6 
 
2.012542574 
 
101.25426 
 
3 1 2 
2354.9 
 
2.997188733 
 
99.718873 
 
4 1 3 
3112.5 
 
4.009406931 
 
100.94069 
 
5 1 4 
3831.4 
 
5.004919717 
 
100.49197 
 
    Mean 100.9346 
    Std.dev 0.9436 
 
              
 
  
 
 
HPTLC densitogram  for recovery of  sultamcillintosilate 
 
 
 
Conclusion: The estimated percentage recovery was found to be close to 100% and hence 
prove the recovery of the method. The percentage recovery of sultamcillintosilate in the 
marketed formulation tablets was found to be in the range of 99.7188%-102.270% and which 
is well within the acceptance limit of 97% - 103%w/w. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           Results and discussion 
 
 
  
 
 
                                   RESULTS AND DISCUSSION 
 
 
The working conditions for the HPTLC method was established for sultamcillin tosylate and 
then applied on pharmaceutical dosage forms. 
 
 
Various types of solvent systems were evaluated to obtain an optimum resolution of drug. 
Acetonitrile: Methanol: Water (3.5:5:1.5 v/v/v) gave the better resolution and precision. The 
detection was carried out at 215nm 
 
 
The retention factor is 0.65 for sultamcillin tosylate. The quantitative estimation report 
sultamcillin tosylate given in table-21. 
 
 
From the linearity studies, the specified concentration range was determined. The linearity 
range is 1-6 µg/spot for sultamcillin tosylate found to obey the linearity with the correlation 
coefficient of 0.9963. The linearity curve for sultamcillin tosylate was shown in the figure-
15,16,17.  
 
 
The validation of the proposed method was verified by system precision. The %RSD for 
system precision for sultamcillin tosylate was calculated. 
 
 
 The validation of the proposed method was also verified by recovery studies. The percentage 
recovery range was found to be satisfied which is represented in the table-26. 
 
 
The parameters including flow rate, temperature, detection wavelength and sensitivity were 
maintained constant throughout the procedure. 
 
 
  
 
 
VALIDATION PARAMETERS 
                                                                     Table-22 
 Parameters                                                            Results 
 
 
Limit of detection                                                        0.0177µg/spot 
 
Limit of quantification                                                        0.05368µg/spot 
 
Linearity range(µg/spot) 
 
                                                       1-6µg/spot 
 
Correlation coefficient                                                            0.9963 
 
Slope                                                           726.25 
 
Intercept                                                          120.71 
 
Percentage Recovery                                                 99.7188%-102.270% 
 
Accuracy                                                      99.975% 
 
Precision(% RSD )                                                      0.5972 
 
Assay(% purity)                                                  99.5619%-99.7030% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
                                   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
         Summary and conclusion 
  
 
              SUMMMARY AND CONCLUSION 
 
 
        SUMMARY OF VALIDATION FOR SULTAMCILLIN TOSILATE BY HPLC 
 
 
 
 
       Parameter        Observation Acceptance 
criterion 
Result 
1 System 
suitability 
0.54 
1.10 
 
           5248.2 
RSD NMT 2.0% 
Tailing NMT 2.5 
Theoretical plates 
NLT 1500 
 
 
Complies 
2 Specifity 
i) Retention 
Time 
 ii) By Placebo 
 method 
 
No interference at 
principle peak RT 
There should be 
no interfering 
peak from the 
placebo and 
diluent 
 
 
Complies 
3 Method 
precision 
            0.8507 RSD NMT 3.0 % Complies 
4 Linearity     
           0.9996 
 
         NLT 0.99 
 
Complies 
6 Accuracy      99.78 – 100.80 98.0% to 102.0% Complies 
7 Robustness 
AT 213 
AT 217 
 
           0.7933 
           0.7927 
 
RSD NMT 5.0 % 
 
Complies 
8 Solution 
stability solution 
stability-table top 
At 1st hour 
At 4th hour 
 
 
 
 
0.05 
1.54 
 
 
 
 
 
± 1.5% 
 
 
 
 
Complies 
 solution 
stability-
refrigerated 
At 1st hour 
At 12th hour 
 
 
 0.05 
1.69             
 
 
± 1.5% 
 
 
 
Complies 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 SUMMARY OF  VALIDATION FOR  SULTAMCILLIN TOSILATE  BY  
HPTLC   
 
 Parameters Results 
 
Acceptance criteria 
 
Limit of 
detection 
0.0177µg/spot 
 
--- 
 
Limit of 
quantification 
0.05368µg/spot 
 
--- 
 
Linearity 
range(µg/spot) 
 
1-6 µg/spot 
 
--- 
 
Correlation 
coefficient 
0.9963 
 
>0.9960 
 
Slope 726.25 
 
--- 
 
Intercept 120.71 
 
--- 
 
Percentage 
Recovery 
99.7188%-102.270% 
 
97-103%w/w 
 
Accuracy 99.975% 
 
Should be close to 100% 
 
Precision(% 
RSD ) 
0.5972 
 
< 2% 
 
Assay(% 
purity) 
99.5619%-99.7030% 
 
97 – 103%w/w 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
CONCLUSION 
 
                                          A RP-HPLC method was developed for the estimation of 
Sultamcillintosilate in a tablet dosage form utilizing HPLC SHIMADZU 2010 
PROMINENCE -separation module withUV-VIS detector kromasilC18 
3.5µ(100mm×4.6mm) Injection volume of 10 μl is injected and eluted with the mobile phase 
of buffer and Acetonitrile in the ratio of 80:20 which is pumped at the flow rate of 1.0ml/min 
and detected at 215 nm wavelength using uv-vis detector. The run time per sample is  20 min. 
The peaks for Sultamcillin tosilate were found at 9.05. The excipients in the formulation did 
not interfere in the accurate estimation of Sultamcillin tosilate. The developed method was 
validated for accuracy, precision, linearity, specificity, and sensitivity in accordance with 
International Conference on Harmonization guidelines .The proposed method is applied for 
determination for Sultamcillin tosilate new formulation. Since none of the methods is 
reported estimation of Sultamcillin tosilate in oral dosage form, this developed method can be 
used for routine analysis of component in formulation. 
 
                                        A simple, and selective high performance thin layer 
chromatographic method was developed and validated for estimation of Sultamcillin tosilate 
pharmaceutical dosage forms. The method employed precoated TLC aluminum plates with 
silica gel 60F254 as the stationary phase. The solvent system comprised Acetonitrile: 
Methanol:Water(3.5:5:1.5 v/v/v). 
 The retention factor is 0.65min for sultamcillin tosilate. Spectrodensitometric scanning 
integration was performed 215 nm. The polynomial regression data for the calibration graph 
showed good linear relationship with R2 = 0.9963 in the concentration range of 1-6 µg/spot. 
The developed method was validated for precision and recovery. The proposed method is 
applied for determination for sultamcillintosilate. 
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